$REGN (Regeneron Pharmaceuticals) Support & Resistance Levels, AI Price Target & Institutional Flow.
Today, $REGN (Regeneron Pharmaceuticals) trades at $920.69 (-0.19%) with a 35/100 Momentum Pulse (STORMY) and 14D RSI at 40.3 (PULLBACK ZONE (40.3)). Unlock the live $REGN support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $REGN.
Regeneron Pharmaceuticals (REGN) is down today following the announcement of multiple class-action lawsuits filed on August 11, 2026, alleging securities fraud related to misleading statements about its failed Phase III Fianlimab-Libtayo Study.
$REGN (Regeneron Pharmaceuticals) Live Key Levels, RSI & Valuation Matrix
| $REGN Technical Metric | Live Value | $REGN Fundamental / Regime Metric | Live Status |
|---|---|---|---|
| Live Spot Price (24h Change) | $920.69 (-0.19%) | Market Capitalization | Tracked in Terminal |
| 30-Day Mechanical Support Floor (Put Wall) | $752.35 (18.28% cushion) | 52-Week High / Low Range | $591.52 – $991.73 |
| 20-Day Simple Moving Average (20D SMA) | $912.02 | Trailing P/E Ratio & Dividend Yield | Growth / N/A • Yield: 0.41% |
| 10-Day Exponential Moving Average (10D EMA) | $935.02 | Average Daily Volume (Liquidity) | 843.6K shares |
| 30-Day Resistance Ceiling (Call Wall) | $972.37 (5.61% upside to test) | Next Scheduled Earnings / Catalyst Window | 2026-10-30 |
| 14-Day Relative Strength Index (RSI) | PULLBACK ZONE (40.3) | Saku Momentum Pulse & Health Rating | 35/100 Momentum • 45/100 Health |
Should You Buy $REGN Stock Now or Wait?
Regeneron's strong pipeline and existing successful drugs offer long-term growth potential despite current legal challenges.
The ongoing class-action lawsuits and past failure of the Phase III Fianlimab-Libtayo Study could lead to significant financial penalties and reputational damage.
$REGN Support & Resistance, Institutional Flow & Catalysts.
$REGN Support & Resistance
Spot Price: $920.69 | 30-Day Support Floor: $752.35 (18.28% above) | 10-Day EMA: $935.02 | 20-Day SMA Pivot: $912.02 | 30-Day Resistance Ceiling: $972.37 (5.61% below) | 14-Day RSI: 40.3 (PULLBACK ZONE (40.3)) | 30-Day Trading Corridor: 29.24% span. AI Desk Note: Immediate support is near today's low of $773.82, while immediate resistance is around today's high of $809.02.
$REGN Institutional & Whale Flow
Whale flow data for today's specific movement is not immediately discernible from public news or SEC filings, though institutional investors collectively hold a significant portion of the stock.
$REGN Catalyst Outlook
The next specific event to watch is the lead plaintiff deadline for the class-action lawsuit on September 14, 2026.
Latest $REGN (Regeneron Pharmaceuticals) Breaking News & Headlines
About Regeneron Pharmaceuticals ($REGN)
Regeneron Pharmaceuticals ($REGN) is an actively traded institutional asset tracked inside the Saku AI Terminal.
Saku's quantitative engine continuously monitors $REGN's 30-day mechanical support floor ($752.35), 20-day simple moving average ($912.02), and 30-day resistance ceiling ($972.37) alongside off-exchange dark pool block prints and SEC filings.
Hatch Your Own 24/7 AI Co-Pilot to Guard $REGN.
Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $REGN 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

What are the live 30-day support and resistance levels for $REGN (Regeneron Pharmaceuticals)?
Spot Price: $920.69 | 30-Day Support Floor: $752.35 (18.28% above) | 10-Day EMA: $935.02 | 20-Day SMA Pivot: $912.02 | 30-Day Resistance Ceiling: $972.37 (5.61% below) | 14-Day RSI: 40.3 (PULLBACK ZONE (40.3)) | 30-Day Trading Corridor: 29.24% span. AI Desk Note: Immediate support is near today's low of $773.82, while immediate resistance is around today's high of $809.02. $REGN currently registers a Saku Momentum Pulse score of 35/100 and a Fundamental Health score of 45/100.
Why is $REGN (Regeneron Pharmaceuticals) moving and what is the bull vs. bear thesis?
Bull Thesis: Regeneron's strong pipeline and existing successful drugs offer long-term growth potential despite current legal challenges. Bear Thesis: The ongoing class-action lawsuits and past failure of the Phase III Fianlimab-Libtayo Study could lead to significant financial penalties and reputational damage.
What are $REGN's key fundamentals, 52-week range, and upcoming catalysts?
Regeneron Pharmaceuticals ($REGN) trades with a market cap of tracked institutional scale, and a 52-week range of $591.52 to $991.73. The next specific event to watch is the lead plaintiff deadline for the class-action lawsuit on September 14, 2026.